Drug Of Abuse Testing Global Market Report 2026

Drug of abuse testing is a structured and scientific method used to identify and quantify substances in biological samples that can influence mood, behavior, or perception. It involves detailed examination of collected specimens to reliably determine the presence of illegal, regulated, or potentially dangerous drugs. It plays a crucial role in tracking substance use trends, assisting clinical assessments, and improving knowledge of how these substances impact individuals and society.

The primary product and services of drug of abuse testing include rapid testing devices, urine testing devices, oral fluid saliva testing devices, analyzers, consumables, and laboratory services. Rapid testing devices refer to diagnostic tools that enable fast detection of drugs in biological samples for screening purposes. These products and services are applied to sample types including urine, oral fluid saliva, hair, breath, blood, and sweat, and are used for detecting drug categories such as psychostimulants, narcotics, cannabinoids, sedatives, and other drug types. Testing is carried out using techniques such as immunoassay, chromatography, and rapid testing methods, and is utilized by end users including hospitals, diagnostic laboratories, forensic laboratories, and other end users.

Tariffs are affecting the drug of abuse testing market by driving up the cost of imported diagnostic reagents, analyzers, and testing consumables, which in turn is causing disruptions in supply chains and increasing operational expenses for laboratories and healthcare providers. Major impacted segments include rapid testing devices, analyzers, and consumables, with urine and oral fluid testing experiencing the highest impact due to dependence on globally sourced kits. Regions such as North America and Asia-Pacific are witnessing procurement delays and stronger pricing pressure across forensic and hospital laboratory settings. At the same time, tariffs are supporting the growth of local manufacturing for testing kits and reagents, fostering regional supply chain expansion and enhancing long-term self-sufficiency in diagnostic testing infrastructure.

The drug of abuse testing market research report is one of a series of new reports from The Business Research Company that provides drug of abuse testing market statistics, including drug of abuse testing industry global market size, regional shares, competitors with a drug of abuse testing market share, detailed drug of abuse testing market segments, market trends and opportunities, and any further data you may need to thrive in the drug of abuse testing industry. This drug of abuse testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug of abuse testing market size has grown strongly in recent years. It will grow from $7.16 billion in 2025 to $7.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to manual laboratory confirmation methods dependency, expansion of workplace drug screening regulations, growth of forensic toxicology laboratories, introduction of immunoassay testing techniques, increasing opioid crisis awareness programs.

The drug of abuse testing market size is expected to see strong growth in the next few years. It will grow to $9.97 billion by 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising substance abuse monitoring initiatives, expansion of mandatory workplace testing policies, increased adoption of rapid point of care testing kits, growing forensic and criminal investigation demand, expansion of global rehabilitation and treatment programs. Major trends in the forecast period include Point of care rapid drug screening adoption, workplace drug testing compliance expansion, forensic toxicology laboratory specialization growth, sports and athletic anti-doping testing programs, emergency department toxicology screening protocols.

The rising prevalence of substance abuse and addiction is anticipated to propel the growth of the drug of abuse testing market coming years. Substance abuse and addiction refer to the harmful or hazardous use of psychoactive substances, including illicit drugs and prescription medications, which can impair health, safety, and social or legal functioning. The prevalence of substance abuse and addiction is growing due to easier access to drugs and changing social behaviors that normalize or increase drug use. Drug of abuse testing helps address substance abuse and addiction by enabling early detection of drug use, guiding timely medical interventions, monitoring recovery progress, and supporting public health strategies to reduce the harmful impact of substance misuse. For instance, in December 2025, according to the Addiction Policy Forum, a US-based non-profit organization, Of the 48.4 million people with a substance use disorder, 27.9 million had an alcohol use disorder and 28.2 million had a drug use disorder in 2024. Therefore, the rising prevalence of substance abuse and addiction is driving the growth of the drug of abuse testing market.

Leading companies operating in the drug of abuse testing market are focusing on developing advanced products such as multi-analyte clinical drug testing panels to enable faster, more accurate, and comprehensive detection of multiple drugs simultaneously. Multi-analyte clinical drug testing panels are devices that simultaneously detect multiple drugs of abuse from a single sample, helping healthcare and forensic professionals quickly identify substance use with high accuracy and efficiency compared to traditional single-drug tests. For example, in February 2026, Randox USA, a U. S. -based diagnostics company, received 510(k) clearance from the U. S. Food and Drug Administration (FDA) for its Evidence MultiSTAT, an innovative multi-analyte clinical drug testing panel. The device is a fully automated, cartridge-based analyzer that uses patented Biochip Technology to simultaneously detect 15 drugs of abuse from urine in just 21 minutes. It features a simple three-step testing process, pre-filled reagent cartridges, and delivers results with high accuracy comparable to confirmatory laboratory methods. The Evidence MultiSTAT covers a wide range of drug classes, including opioids, fentanyl, methamphetamine, cocaine, benzodiazepines, and cannabinoids, making it suitable for use in hospital laboratories, emergency departments, pain management clinics, behavioral health centers, and forensic settings. This technology improves efficiency, reduces human error, and provides rapid, reliable results compared to traditional single-analyte tests.

In October 2025, Archimed Diagnostics, a France-based healthcare technology company, acquired Ark Diagnostics for an undisclosed value. Through this acquisition, Archimed Diagnostics seeks to strengthen its position in the in vitro diagnostics market by incorporating Ark's expertise in rapid diagnostic testing, thereby expanding its product portfolio with innovative, high-performance solutions for infectious disease detection and point-of-care testing. Ark Diagnostics is a US-based healthcare technology company specializing in drugs of abuse (DoA) testing solutions.

Major companies operating in the drug of abuse testing market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Dragerwerk AG & Co. KGaA, Shimadzu Corporation, Bio-Rad Laboratories Inc., OraSure Technologies, Clinical Reference Laboratory (CRL) Inc., Legacy Medical Services, Intoximeters Inc., Cordant Health Solutions, DrugScan, Premier Biotech Inc., UCP Biosciences, American Screening Corporation Inc., SureHire Inc.

North America was the dominating region in the drug of abuse testing market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the drug of abuse testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug of abuse testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug of abuse testing market includes revenues earned by entities by providing services such as laboratory testing, specimen collection, sample transportation, result interpretation, clinical consultation, workplace drug screening, forensic analysis, point-of-care testing, confirmatory testing, counseling and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Of Abuse Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug of abuse testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug of abuse testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug of abuse testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product And Service: Rapid Testing Devices; Urine Testing Devices; Oral Fluid Saliva Testing Devices; Analyzers; Consumables; Laboratory Services
• 2) By Sample Type: Urine; Oral Fluid Saliva; Hair; Breath; Blood; Sweat
• 3) By Drug Type: Psychostimulants; Narcotics; Cannabinoids; Sedatives; Other Drug Types
• 4) By Technique Type: Immunoassay; Chromatography
• 5) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
• Subsegments:
• 1) By Rapid Testing Devices: Point Of Care Testing Kits; Home Testing Kits; Immunoassay Rapid Test Strips; Portable Screening Devices
• 2) By Urine Testing Devices: Urine Collection Kits; Urine Screening Test Strips; Cup Based Testing Devices; Laboratory Urine Test Kits
• 3) By Oral Fluid Saliva Testing Devices: Saliva Collection Kits; Oral Fluid Screening Devices; Disposable Oral Swab Kits; Portable Saliva Analyzers
• 4) By Analyzers: Immunoassay Analyzers; Chromatography Analyzers; Mass Spectrometry Analyzers; Point Of Care Analyzers
• 5) By Consumables: Test Strips And Reagents; Sample Collection Tubes; Control And Calibration Kits; Disposable Pipettes And Swabs
• 6) By Laboratory Services: Drug Screening Services; Confirmatory Testing Services; Sample Collection And Processing Services; Data Reporting And Analysis Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Quest Diagnostics Incorporated; Dragerwerk AG & Co. KGaA; Shimadzu Corporation; Bio-Rad Laboratories Inc.; OraSure Technologies; Clinical Reference Laboratory (CRL) Inc.; Legacy Medical Services; Intoximeters Inc.; Cordant Health Solutions; DrugScan; Premier Biotech Inc.; UCP Biosciences; American Screening Corporation Inc.; SureHire Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.